Pharmaceutical composition comprising (E) -7- [4- (4-fluorophenyl) - 6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5 -yl- (3R, 5S) -3, 5-dihydr0xyhept-6-en0ic acid
Details for Australian Patent Application No. 2006329006 (hide)
International Classifications
Event Publications
10 July 2008 PCT application entered the National Phase
PCT publication WO2007/071357 Priority application(s): WO2007/071357
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006329007-Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
2006329005-Process for removing residual volatile monomers from a polymer in powder form
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser